Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Palladone SR 4mg capsules
040702050BBADAG
|
Palladone | Hydromorphone hydrochloride | Central Nervous System | 68 |
|
Palladone 1.3mg capsules
040702050BBAAAE
|
Palladone | Hydromorphone hydrochloride | Central Nervous System | 67 |
|
Palladone SR 8mg capsules
040702050BBAEAC
|
Palladone | Hydromorphone hydrochloride | Central Nervous System | 36 |
|
Palladone 2.6mg capsules
040702050BBABAD
|
Palladone | Hydromorphone hydrochloride | Central Nervous System | 35 |
|
Palladone SR 2mg capsules
040702050BBACAF
|
Palladone | Hydromorphone hydrochloride | Central Nervous System | 32 |
|
Palladone SR 16mg capsules
040702050BBAFAA
|
Palladone | Hydromorphone hydrochloride | Central Nervous System | 16 |
|
Palladone SR 24mg capsules
040702050BBAGAB
|
Palladone | Hydromorphone hydrochloride | Central Nervous System | 16 |
|
Palladone 10mg/1ml solution for injection ampoules
040702050BBAJAN
|
Palladone | Hydromorphone hydrochloride | Central Nervous System | 2 |
|
Palladone 20mg/1ml solution for injection ampoules
040702050BBAIAM
|
Palladone | Hydromorphone hydrochloride | Central Nervous System | No data available |
|
Palladone 2mg/1ml solution for injection ampoules
040702050BBAHAL
|
Palladone | Hydromorphone hydrochloride | Central Nervous System | No data available |
|
Palladone 50mg/1ml solution for injection ampoules
040702050BBAKAP
|
Palladone | Hydromorphone hydrochloride | Central Nervous System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.